Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer.

52W Range

52ndpctl

Volume

0.59×avg

Market Cap

1.73BUSD

P/E Ratio

-7.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Syndax Pharmaceuticals, Inc.

SNDXNASDAQ Global Select·USD·Closed

Syndax Pharmaceuticals, Inc.

SNDXNASDAQ·USD·Closed

$19.54

−3.08%

$19.54

−$0.62 (3.08%)

52W Range

52ndpctl

Volume

0.59×avg

Mkt Cap

1.73BUSD

P/E

-7.8TTM

Div Yield

–ann

SNDX: Syndax Pharmaceuticals, Inc. Stock Analysis | finqOS